 |
(S)-10-[(dimethylamino)methyl]-4-ethyl-9-hydroxy-4-O-[alpha-(2”, 4”, 5”, 7”-tetranitro-9”-fluorenylideneaminooxy)propionyl]-1H-pyrano[3′, 4′, 6′, 7′]indolizino[1,2-beta]-quinoline-3, 14-(4H), 12H)-dione, hydrochloride |
|---|---|
| Trade Name | |
| Orphan Indication | Hepatocellular Carcinoma |
| EU Market Approval | EU |
| EU Designation Date | 2010-10-01 00:00:00 |
| Sponsor | TLC Biopharmaceuticals B.V. |
